Critical Survey: Autonomix Medical (AMIX) versus The Competition

Autonomix Medical (NASDAQ:AMIX) is one of 237 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Autonomix Medical to related businesses based on the strength of its valuation, analyst recommendations, institutional ownership, earnings, profitability, dividends and risk.

Profitability

This table compares Autonomix Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.36%	-156.80%	-27.37%

Analyst Ratings

This is a summary of recent ratings and target prices for Autonomix Medical and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1929	4928	9165	269	2.48

Autonomix Medical presently has a consensus target price of $28.00, indicating a potential upside of 623.51%. As a group, “Surgical & medical instruments” companies have a potential upside of 16.40%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than its rivals.

Institutional & Insider Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by insiders. Comparatively, 15.4% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Autonomix Medical and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.24
Autonomix Medical Competitors	$1.04 billion	$10.57 million	-7.04

Autonomix Medical’s rivals have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.